Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1416

1.

German second-opinion network for testicular cancer: sealing the leaky pipe between evidence and clinical practice.

Zengerling F, Hartmann M, Heidenreich A, Krege S, Albers P, Karl A, Weissbach L, Wagner W, Bedke J, Retz M, Schmelz HU, Kliesch S, Kuczyk M, Winter E, Pottek T, Dieckmann KP, Schrader AJ, Schrader M; GTCSG (German Testicular Cancer Study Group).

Oncol Rep. 2014 Jun;31(6):2477-81. doi: 10.3892/or.2014.3153. Epub 2014 Apr 24.

PMID:
24788853
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Concept and viability of androgen annihilation for advanced prostate cancer.

Mohler JL.

Cancer. 2014 Sep 1;120(17):2628-37. doi: 10.1002/cncr.28675. Epub 2014 Apr 25. Review.

PMID:
24771515
[PubMed - indexed for MEDLINE]
3.

Validation of endogenous normalizing genes for expression analyses in adult human testis and germ cell neoplasms.

Svingen T, Jørgensen A, Rajpert-De Meyts E.

Mol Hum Reprod. 2014 Aug;20(8):709-18. doi: 10.1093/molehr/gau030. Epub 2014 Apr 17.

PMID:
24743772
[PubMed - in process]
4.

First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG).

Berger LA, Bokemeyer C, Lorch A, Hentrich M, Kopp HG, Gauler TC, Beyer J, de Wit M, Mayer F, Boehlke I, Oing C, Honecker F, Oechsle K.

J Cancer Res Clin Oncol. 2014 Jul;140(7):1211-20. doi: 10.1007/s00432-014-1661-z. Epub 2014 Apr 3.

PMID:
24696231
[PubMed - indexed for MEDLINE]
5.

Antiemetic efficacy and safety of a combination of palonosetron, aprepitant, and dexamethasone in patients with testicular germ cell tumor receiving 5-day cisplatin-based combination chemotherapy.

Hamada S, Hinotsu S, Kawai K, Yamada S, Narita S, Kamba T, Nishiyama H, Arai Y, Habuchi T, Ogawa O, Kawakami K.

Support Care Cancer. 2014 Aug;22(8):2161-6. doi: 10.1007/s00520-014-2182-7. Epub 2014 Mar 21.

PMID:
24652048
[PubMed - indexed for MEDLINE]
6.

Three authors reply.

Cortessis VK, Phay Johnson Thomas J, Thomas DC.

Am J Epidemiol. 2014 Apr 15;179(8):1037. doi: 10.1093/aje/kwu042. Epub 2014 Mar 19. No abstract available.

PMID:
24647848
[PubMed - indexed for MEDLINE]
7.

Re: "Null association between histology of first and second primary malignancies in men with bilateral testicular germ cell tumors".

Stang A, Rusner C.

Am J Epidemiol. 2014 Apr 15;179(8):1036. doi: 10.1093/aje/kwu045. Epub 2014 Mar 19. No abstract available.

PMID:
24647845
[PubMed - indexed for MEDLINE]
8.

Reply to G. Gandaglia et al.

Fung C, Fossa SD, Milano MT, Oldenburg J, Travis LB.

J Clin Oncol. 2014 Apr 10;32(11):1167-9. doi: 10.1200/JCO.2013.54.6168. Epub 2014 Mar 3. No abstract available.

PMID:
24590643
[PubMed - indexed for MEDLINE]
9.

Cisplatin-based chemotherapy and the risk of solid tumors in patients with testicular nonseminoma: still a matter of debate.

Gandaglia G, Karakiewicz PI, Trinh QD, Sun M.

J Clin Oncol. 2014 Apr 10;32(11):1167. doi: 10.1200/JCO.2013.53.6482. Epub 2014 Mar 3. No abstract available.

PMID:
24590641
[PubMed - indexed for MEDLINE]
10.

CMTM3 inhibits human testicular cancer cell growth through inducing cell-cycle arrest and apoptosis.

Li Z, Xie J, Wu J, Li W, Nie L, Sun X, Tang A, Li X, Liu R, Mei H, Wang F, Wang Z, Gui Y, Cai Z.

PLoS One. 2014 Feb 28;9(2):e88965. doi: 10.1371/journal.pone.0088965. eCollection 2014.

PMID:
24586462
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study.

Bilmon IA, Ashton LJ, Le Marsney RE, Dodds AJ, O'Brien TA, Wilcox L, Nivison-Smith I, Daniels B, Vajdic CM; CAST study group.

Bone Marrow Transplant. 2014 May;49(5):691-8. doi: 10.1038/bmt.2014.13. Epub 2014 Feb 17.

PMID:
24535126
[PubMed - indexed for MEDLINE]
12.

[Seminona of stage I: strategies compared].

Tana S, Avuzzi B.

Urologia. 2013 Jul-Sep;80(3):207-11. doi: 10.5301/RU.2013.11546. Epub 2013 Oct 15. Italian.

PMID:
24526597
[PubMed - in process]
13.

Incidence of second sarcomas: a cancer registry-based study.

Levi F, Randimbison L, Maspoli-Conconi M, Blanc-Moya R, La Vecchia C.

Cancer Causes Control. 2014 Apr;25(4):473-7. doi: 10.1007/s10552-014-0349-7. Epub 2014 Jan 25.

PMID:
24463790
[PubMed - in process]
14.

Risk of second primary cancers after testicular cancer in East and West Germany: a focus on contralateral testicular cancers.

Rusner C, Streller B, Stegmaier C, Trocchi P, Kuss O, McGlynn KA, Trabert B, Stang A.

Asian J Androl. 2014 Mar-Apr;16(2):285-9. doi: 10.4103/1008-682X.122069.

PMID:
24407180
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

[Flagellate dermatitis after bleomycin chemotherapy in a patient with malignant germ cell tumor].

Schummer C, Winkler Y, Tittelbach J, Grimm MO, Elsner P.

Dtsch Med Wochenschr. 2014 Jan;139(3):84-6. doi: 10.1055/s-0033-1359878. Epub 2014 Jan 7. German.

PMID:
24399654
[PubMed - indexed for MEDLINE]
16.

Update in systemic therapy of urologic malignancies.

Mooney D, Paluri R, Mehta A, Goyal J, Sonpavde G.

Postgrad Med. 2014 Jan;126(1):44-54. doi: 10.3810/pgm.2014.01.2724. Review.

PMID:
24393751
[PubMed - indexed for MEDLINE]
17.

Testicular cancer in 2013: towards personalized medicine--are we there yet?

Oldenburg J, Fosså SD.

Nat Rev Urol. 2014 Feb;11(2):68-9. doi: 10.1038/nrurol.2013.298. Epub 2013 Dec 24.

PMID:
24366345
[PubMed - indexed for MEDLINE]
18.

Prostatic metastases from testicular nonseminomatous germ cell cancer: two case reports and a review of the literature.

Torelli T, Lughezzani G, Catanzaro M, Nicolai N, Colecchia M, Biasoni D, Piva L, Maffezzini M, Stagni S, Necchi A, Giannatempo P, Farè E, Salvioni R.

Tumori. 2013 Sep-Oct;99(5):e203-7. doi: 10.1700/1377.15315. Review.

PMID:
24362870
[PubMed - indexed for MEDLINE]
19.

Predictors of CD34+ cell mobilization and collection in adult men with germ cell tumors: implications for the salvage treatment strategy.

Necchi A, Miceli R, Pedrazzoli P, Giannatempo P, Secondino S, Di Nicola M, Farè E, Raggi D, Magni M, Matteucci P, Longoni P, Milanesi M, Paternò E, Ravagnani F, Arienti F, Nicolai N, Salvioni R, Carlo-Stella C, Gianni AM.

Clin Genitourin Cancer. 2014 Jun;12(3):196-202.e1. doi: 10.1016/j.clgc.2013.11.021. Epub 2013 Nov 13.

PMID:
24361054
[PubMed - in process]
20.

Late gastrointestinal morbidity in patients with stage I-II testicular seminoma treated with radiotherapy.

Hallemeier CL, Davis BJ, Pisansky TM, Choo R.

Urol Oncol. 2014 May;32(4):496-500. doi: 10.1016/j.urolonc.2013.10.002. Epub 2013 Dec 12.

PMID:
24332645
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk